Growth Metrics

CVRx (CVRX) Other Accumulated Expenses (2020 - 2026)

CVRx's quarterly Other Accumulated Expenses came in at $1.2 million in Q1 2026, up 45.93% year-on-year from $799000.0 in Q1 2025, and up 83.05% quarter-over-quarter from $637000.0 in Q4 2025.

CVRx has reported Other Accumulated Expenses for 7 years, with the latest figure at $1.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Accumulated Expenses rose 45.93% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 45.93% YoY), and the FY2025 full-year result was $637000.0, down 27.45% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $1.2 million, up from $637000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $1.2 million in Q1 2026, with the low at $531000.0 in Q1 2022.
  • Average Other Accumulated Expenses over 5 years is $831647.1, with a median of $823000.0 recorded in 2022.
  • Year-over-year, Other Accumulated Expenses surged 132.73% in 2022 and slumped 41.92% in 2025.
  • Tracing CVRX's Other Accumulated Expenses over 5 years: stood at $775000.0 in 2022, then decreased by 21.16% to $611000.0 in 2023, then surged by 43.7% to $878000.0 in 2024, then fell by 27.45% to $637000.0 in 2025, then surged by 83.05% to $1.2 million in 2026.
  • The last three Other Accumulated Expenses figures came in at $1.2 million (Q1 2026), $637000.0 (Q4 2025), and $611000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 CVRx 144.43 Mn 72.13 Mn 12.88 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.17 Mn
Dec 31, 2025 637,000.00
Sep 30, 2025 611,000.00
Jun 30, 2025 1.03 Mn
Mar 31, 2025 799,000.00
Dec 31, 2024 878,000.00
Sep 30, 2024 1.05 Mn
Jun 30, 2024 951,000.00
Mar 31, 2024 797,000.00
Dec 31, 2023 611,000.00
Sep 30, 2023 869,000.00
Jun 30, 2023 1.09 Mn
Mar 31, 2023 977,000.00
Dec 31, 2022 775,000.00
Sep 30, 2022 823,000.00
Jun 30, 2022 541,000.00
Mar 31, 2022 531,000.00
Dec 31, 2021 333,000.00
Sep 30, 2021 537,000.00
Jun 30, 2021 658,000.00
Dec 31, 2020 149,000.00